Literature DB >> 31167919

In Vitro and In Vivo Inhibition of the Infectivity of Human Enterovirus 71 by a Sulfonated Food Azo Dye, Brilliant Black BN.

Tao Meng1,2, Qiang Jia1, Sek-Man Wong3,2,4, Kaw-Bing Chua3.   

Abstract

Hand, foot, and mouth disease (HFMD), a highly contagious disease in children, is caused by human enteroviruses, including enterovirus 71 (EV71), coxsackievirus A16 (CVA16), and coxsackievirus A6 (CVA6). Although HFMD is usually mild and self-limiting, EV71 infection occasionally leads to fatal neurological disorders. Currently, no commercial antiviral drugs for HFMD treatment are available. Here, numerous sulfonated azo dyes, widely used as food additives, were identified as having potent antiviral activities against human enteroviruses. Among them, brilliant black BN (E151) was able to inhibit all EV71, CVA16, and CVA6 strains tested. In rhabdomyosarcoma cells, the 50% inhibitory concentrations of the dye E151 for various strains of EV71 ranged from 2.39 μM to 28.12 μM, whereas its 50% cytotoxic concentration was 1,870 μM. Food azo dyes, including E151, interacted with the vertex of the 5-fold axis of EV71 and prevented viral entry. Their efficacy in viral inhibition was regulated by amino acids at VP1-98, VP1-145, and/or VP1-246. Dye E151 not only prevented EV71 attachment but also eluted attached viruses in a concentration-dependent manner. Moreover, E151 inhibited the interaction between EV71 and its cellular uncoating factor cyclophilin A. In vivo studies demonstrated that E151 at a dose of 200 mg/kg of body weight/day given on the initial 4 days of challenge protected AG129 mice challenged with 10× the 50% lethal dose of wild-type EV71 isolates. Taken together, these data highlight E151 as a promising antiviral agent against EV71 infection.IMPORTANCE Human enterovirus 71 (EV71) is one of the causative agents of hand, foot, and mouth disease in children and is responsible for thousands of deaths in the past 20 years. Food azo dyes have been widely used since the nineteenth century; however, their biological effects on humans and microbes residing in humans are poorly understood. Here, we discovered that one of these dyes, brilliant black BN (E151), was particularly effective in inhibiting the infectivity of EV71 in both cell culture and mouse model studies. Mechanistic studies demonstrated that these sulfonated dyes mainly competed with EV71 attachment factors for viral binding to block viral attachment/entry to host cells. As no commercial antiviral drugs against EV71 are currently available, our findings open an avenue to exploit the development of permitted food dye E151 as a potential anti-EV71 agent.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  AG129 mouse; antiviral agent; food azo dye; hand foot and mouth disease; human enterovirus; sulfonate; virus attachment factors; virus entry

Mesh:

Substances:

Year:  2019        PMID: 31167919      PMCID: PMC6694806          DOI: 10.1128/JVI.00061-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

Review 1.  Remediation of dyes in textile effluent: a critical review on current treatment technologies with a proposed alternative.

Authors:  T Robinson; G McMullan; R Marchant; P Nigam
Journal:  Bioresour Technol       Date:  2001-05       Impact factor: 9.642

2.  Enterovirus 71 outbreak in the People's Republic of China in 2008.

Authors:  Fan Yang; Lili Ren; Zhaohui Xiong; Jianguo Li; Yan Xiao; Rong Zhao; Yaqing He; Ge Bu; Shili Zhou; Jianwei Wang; Jin Qi
Journal:  J Clin Microbiol       Date:  2009-05-13       Impact factor: 5.948

3.  Cardiopulmonary manifestations of fulminant enterovirus 71 infection.

Authors:  Jing-Ming Wu; Jieh-Neng Wang; Yu-Chien Tsai; Ching-Chuan Liu; Chao-Ching Huang; Yung-Jung Chen; Tsu-Fuh Yeh
Journal:  Pediatrics       Date:  2002-02       Impact factor: 7.124

4.  Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997-1998.

Authors:  H Shimizu; A Utama; K Yoshii; H Yoshida; T Yoneyama; M Sinniah; M A Yusof; Y Okuno; N Okabe; S R Shih; H Y Chen; G R Wang; C L Kao; K S Chang; T Miyamura; A Hagiwara
Journal:  Jpn J Infect Dis       Date:  1999-02       Impact factor: 1.362

5.  Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease.

Authors:  L Y Chang; T Y Lin; K H Hsu; Y C Huang; K L Lin; C Hsueh; S R Shih; H C Ning; M S Hwang; H S Wang; C Y Lee
Journal:  Lancet       Date:  1999-11-13       Impact factor: 79.321

6.  Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia.

Authors:  P McMinn; I Stratov; L Nagarajan; S Davis
Journal:  Clin Infect Dis       Date:  2000-12-28       Impact factor: 9.079

7.  Scavenger receptor B2 is a cellular receptor for enterovirus 71.

Authors:  Seiya Yamayoshi; Yasuko Yamashita; Jifen Li; Nobutaka Hanagata; Takashi Minowa; Taro Takemura; Satoshi Koike
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

8.  Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71.

Authors:  Yorihiro Nishimura; Masayuki Shimojima; Yoshio Tano; Tatsuo Miyamura; Takaji Wakita; Hiroyuki Shimizu
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

9.  The evaluation of the genotoxicity of two commonly used food colors: Quinoline Yellow (E 104) and Brilliant Black BN (E 151).

Authors:  Violetta K Macioszek; Andrzej K Kononowicz
Journal:  Cell Mol Biol Lett       Date:  2004       Impact factor: 5.787

Review 10.  Virus entry: molecular mechanisms and biomedical applications.

Authors:  Dimiter S Dimitrov
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

View more
  6 in total

1.  Enterovirus A71 antivirals: Past, present, and future.

Authors:  Jun Wang; Yanmei Hu; Madeleine Zheng
Journal:  Acta Pharm Sin B       Date:  2021-08-20       Impact factor: 14.903

2.  Novel capsid binder and PI4KIIIbeta inhibitors for EV-A71 replication inhibition.

Authors:  Yong Wah Tan; Wan Keat Yam; Rachel Jia Wen Kooi; Jacob Westman; Gustav Arbrandt; Justin Jang Hann Chu
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

Review 3.  Antivirals and vaccines for Enterovirus A71.

Authors:  Jing-Yi Lin; Yu-An Kung; Shin-Ru Shih
Journal:  J Biomed Sci       Date:  2019-09-03       Impact factor: 8.410

Review 4.  Antivirals blocking entry of enteroviruses and therapeutic potential.

Authors:  Mohd Ishtiaq Anasir; Faisal Zarif; Chit Laa Poh
Journal:  J Biomed Sci       Date:  2021-01-15       Impact factor: 8.410

5.  A Novel Attenuated Enterovirus A71 Mutant with VP1-V238A,K244R Exhibits Reduced Efficiency of Cell Entry/Exit and Augmented Binding Affinity to Sulfated Glycans.

Authors:  Tao Meng; Sek-Man Wong; Kaw-Bing Chua
Journal:  J Virol       Date:  2021-09-01       Impact factor: 5.103

Review 6.  Targeting the Virus Capsid as a Tool to Fight RNA Viruses.

Authors:  Lucie Hozáková; Barbora Vokatá; Tomáš Ruml; Pavel Ulbrich
Journal:  Viruses       Date:  2022-01-18       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.